DOCSLIB.ORG

Antifungal Drugs

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Antifungal Drugs Antifungal Drugs Antifungal or antimycotic drugs are those agents used to treat diseases caused by fungus. Fungicides are drugs which destroy fungus and fungistatic drugs are those which prevent growth and multiplication of fungi. Collectively these drugs are often referred to as antimycotic or antifungal drugs. General characteristics of fungus: Fungi of medical significance are of two groups: Yeast Unicellular (Candida, Crytococcus) Molds Multicellular; filamentous consist of hyphae (Aspergillus, Microsporum, Trichophyton) They are eukaryotic i.e. they have well defined nucleus and other nuclear materials. They are made of thin threads called hyphae. The hyphae have a cell wall (like plant cells) made of a material called chitin. The hyphae are often multinucleate. They do not have chlorophyll, can’t make own food by photosynthesis, therefore derive nutrients by means of saprophytic or parasitic existence. Cell membrane is made up of ergosterol. Types of fungal infections: Fungal infections are termed as mycoses and in general can be divided into: Superficial infections: Affecting skin, nails, scalp or mucous membranes; e.g. Tinea versicolor Dermatophytosis: Fungi that affect keratin layer of skin, hair and nail; e.g. Tinea pedis, rign worm infection. Candidiasis: Yeast infections caused by (Malassezia pachydermatis), oral thrush (oral candidiasis), vulvo-vaginitis, nail infection. Systemic/Deep infections: Affecting deeper tissues and organ they usually affect lungs, heart and brain leading to pneumonia, endocarditis and meningitis. Systemic infections are associated with immunocompromised patients, these diseases are serious and often life threatening due to the organ involved. Some of the serious systemic fungal infections in man are candidiasis, cryptococcal meningitis, pulmonary aspergillosis. In addition blastomycosis, histoplasmosis, coccidiomycosis and paracoccidiomycosis are common fungal infections which often occur as primary infections. In animals Aspergillus fumigatus causes “brooder pneumonia” in chickens and mycotic abortion” in cattle. Superficial fungal infections are classified into dermatomycosis and candidiasis. Ringworm (dermatomycosis or dermatophytosis) is the most common fungal skin disease of man and animal. The dermatophyte which cause ringworms in animals and birds belong to two genera Trichophyton and Microsporum Followings are the species of Trichophyton and Microsporum affecting animals. Trichophyton verrucosum var. discoides - causes outbreaks in cattle and is transmissible in man, also occasionally occurs in horses, dogs and goats. T. mentagrophytes - Dogs, cats. T. equinum - Horses. T. gallinae - Causes favus in poultry. Microsporum canis - Causes ringworm in dogs and cats Microsporum equinum - Occasional outbreaks in horse. These ringworm are transmissible to man and Microsporum spp. is contagious. Classificaiton of antifungal drugs 1. Organic acids and their salts a) Benzoic acid Action: Fungistatic and bacteriostatic b) Salicylic acid Action: Antipyretic and keratolytic Preparation: Whitfield’s ointment: Benzoic acid 6 parts, salicylic acid 3 parts, Vaseline 91 parts. Use: Ringworm/Superficial mycotic infection. 2. Undecylenic acid It is a yellow liquid having fungistatic property. Long exposure with high concentration may have fungicidal effect. High concentrations of the acid have irritant effect so zinc or copper salts of the acid are used to minimize the effect. It is effective against Microsporum spp. 3. Antifungal antibiotics a) Amphotericin B: polyene antibiotic b) Natamycin Polyene antibiotic derived from Streptomyces nataliensis Effective against dermatophytes, bovine yeast mastitis and mycotic keratitis In mastitis caused by Candida spp. 20 ml of 2.5% solution of natamycin is infused into affected teat once daily for 3 days. In ringworm used as suspension containing 1 mg/ml. Animals should be treated indoor or in evening to avoid inactivation which occurs in sunlight c) Griseofulvin Source: Penicillium griseofulvum Highly effective against dermatophytes d) Nystatin Source: Streptomyces noursei Not effective against dermaqtophytes Highly toxic for systemic use 4. Azoles a) Imidazoles: Ketoconzole, miconazole, clotrimozole b) Triazoles: Fluconazole, itraconazole Miconazole nitrate: 2% cream or 1% lotion usually recommended or ringworm of cat or dog. Action: Penetrates chitin of the fungal cell wall with increased permeability. 5. Miscellaneous antifungals a) Dichlorophen Besides its taenicide action, it is a useful fungicide 2% ointment or alcoholic solution against dermataophytes Action: Fungicidal Use: Cattle ringworm b) Monosulfirum: Fungicidal( Ear preparation) c) Copper sulfate Strongly fungicidal and has astringent and caustic property 5% ointment or 1-2% aqueous solutions Use: Cattle ringworm (Farm animal practice) Action: Fungicidal d) Crystal violet Used as 1% alcoholic solution Use: Ringworm Action: Fungistat Classification of antifungal drugs based on their site of/ route of application: i. Topical agents - Benzoic acid - Salicylic acid - Undecylenic acid - Natamycin - Nystatin - Dicholophen - Monosulfiram - Copper sulfate - Crystal violet - Azoles: Miconazole, Clotrimozole ii. Systemic agents a) Antifungal antibiotics - Amphotericin B - Griseofulvin b) Synthetic antifungal agents: Broad spectrum fungistatic agents - Fluconazole - Ketoconazole - Miconazole - Itraconazole - Terbinafine - Flucytosine Griseofulvin works only against ringworm. Nystatin works only against candida Ketoconazole, miconozole, clotrimazole work against dermatophytes + candida Fluconazole + Itraconazole Broad spectrum antifungal drug Polyene macrolide: Contains a large lactone ring with many double bonds. Polyene macrolides include (these are also antifungal antibiotic) amphotericin B, natamycin, nystatin (all are natural) Amphotericin B Amphotericin A and B are polyene antifungal antibiotics Amphotericin A is not used clinically It is a natural broad spectrum antifungal antibiotic Both amphotericin A and B are natural fermentation product of the actinomycetes Streptomyces nodosus It is an amphoteric compound consists of a large macrolide ring with a hydrophobic conjugated double bond chain and a hydrophilic hydroxylated carbon chain and attached sugar. It is a yellowish powder and insoluble in water and somewhat unstable. Mechanism of action: Amphotericin B Binds tightly to ergosterol in fungal cell membrane Forms ‘pores’ and ‘channels’ in the membrane Increase permeability of cell membrane Leakage of intracellular contents Death of the fungi (Fungicidal) Pharmacokinetics: Poorly absorbed from the GI tract, hence is not suitable orally for systemic infection. Effective for fungal infection of gastrointestinal tract and oral yeast infection. For systemic infection given as IV Highly bound to plasma protein; widely distributed to various tissues. Does not cross Blood Brain Barrier (BBB) Metabolized in liver Excreted slowly in urine over a period of several days. Adverse effects: Most toxic of all antifungal agents Nephrotoxicity (tubular damage due to binding of Amphotericin B to cholesterol in the tubular cells) Electrolyte leakage ( renal acidosis) (Monitor Blood urea nitrogen, creatinine, electrolytes) Nausea Vomition Fever Headache Anemia and electrolyte disturbance Hepatotoxicity Use: Effective against Crytococcus spp., Candida spp., Aspergillus spp., Blastomyces and Histoplasma capsulatum Griseofulvin Narrow spectrum fungistatic agent Source: Penicillium griseofulvum Used orally for dermatophytic infections It is colorless, slightly bitter and virtually insoluble in water It is not effective topically It gets concentrated in keratinized tissues such as skin,hair,nail Mechanism of action: Griseofulvin interacts with microtubules and interferes with mitosis. Griseofulvin Interacts with polymerized microtubules Disrupt the mitotic spindle Spindle poison, thus griseofulvin inhibits fungal mitosis Pharmacokinetics: It is available only as an oral preparation. Oral absorption depends on particle size, the less the particle the more/rapid the absorption. Microsized preparations are 25-70% absorbed. Distributed to keratin of skin, hair and nail. the drug is bound tightly to keratinocytes and remains in the skin until these cells are shed. Metabolized in liver (6 times faster in animals than in human). For this reason animal dose is higher than human dose. Excreted through urine. Adverse effects: Mainly occurs in cats. Extremely teratogenic in cats Leucopenia Anemia Headache Malaise Rashes Use: Ringworm/dermatophytic (Microsporum, Trichophyton, Epidermatophyton) infection Dose: Small animals: 25 mg/kg at every 12 hours for 4 weeks Azoles Azole antifungals are broadly classified into imidazoles and triazoles Imidazole ---- ketoconazole, miconazole, clotrimazole. Miconazole, clotrimazole ---- topical use. ketoconazole ----- first orally active imidazole antifungal drug. Triazole--- Fluconazole, itraconazole Imidazoles are less specific than triazoles and produce side effects due to inhibition of CYP- 450. Both of them are structurally related compound, having similar mechanism of action and antifungal spectrum. Broad spectrum fungistatic agents. Mechanism of action: Inhibit synthesis of ergosterol of fungal cell membrane by inhibiting 14∞-demethylase enzyme. Ketoconazole Most popular antifungal agent in veterinary medicine It is effective orally as well as topically (skin and tissue distribution) for various
Load more

Recommended publications
  • Pharmacokinetics of Salicylic Acid Following Intravenous and Oral Administration of Sodium Salicylate in Sheep
    animals Article Pharmacokinetics of Salicylic Acid Following Intravenous and Oral Administration of Sodium Salicylate in Sheep Shashwati Mathurkar 1,*, Preet Singh 2 ID , Kavitha Kongara 2 and Paul Chambers 2 1 1B, He Awa Crescent, Waikanae 5036, New Zealand 2 School of Veterinary Sciences, College of Sciences, Massey University, Palmerston North 4474, New Zealand; [email protected] (P.S.); [email protected] (K.K.); [email protected] (P.C.) * Correspondence: [email protected]; Tel.: +64-221-678-035 Received: 13 June 2018; Accepted: 16 July 2018; Published: 18 July 2018 Simple Summary: Scarcity of non-steroidal anti-inflammatory drugs (NSAID) to minimise the pain in sheep instigated the current study. The aim of this study was to know the pharmacokinetic parameters of salicylic acid in New Zealand sheep after administration of multiple intravenous and oral doses of sodium salicylate (sodium salt of salicylic acid). Results of the study suggest that the half-life of the drug was shorter and clearance was faster after intravenous administration as compared to that of the oral administration. The minimum effective concentration required to produce analgesia in humans (16.8 µL) was achieved in sheep for about 0.17 h in the current study after intravenous administration of 100 and 200 mg/kg body weight of sodium salicylate. However, oral administration of these doses failed to achieve the minimum effective concentration as mentioned above. This study is of significance as it adds valuable information on pharmacokinetics and its variation due to breed, species, age, gender and environmental conditions.
    [Show full text]
  • Original Article Interaction of Candida Albicans with Fluconazole
    International Journal of Medical Laboratory 2020;7(2):110-120. Original Article Interaction of Candida albicans with Fluconazole/ Clotrimazole: Effect on Hyphae Formation and Expression of Hyphal Wall Protein 1 Sakineh Jam Shahriari1 M.Sc., Fahimeh Alizadeh1* Ph.D. Alireza Khodavandi2 Ph.D. 1Department of Microbiology, Yasooj Branch, Islamic Azad University, Yasooj, Iran. 2Department of Biology, Gachsaran Branch, Islamic Azad University, Gachsaran, Iran. A B S T R A C T Article history Background and Aims: Candida albicans (C. albicans) is the most common Received 20 May 2019 opportunistic human pathogen. Therapeutic options for Candida infections are Accepted 22 Jul 2019 limited to available antifungal drugs. The aim of this study was to investigate Available online 30 May 2020 the effects of fluconazole/clotrimazole (FLU/CLT) on C. albicans hyphae Key words formation. Candida albicans Materials and Methods: We have established the effectiveness of the Clotrimazole combination of FLU/CLT on C. albicans hyphae formation. Interaction of C. Fluconazole Hyphae albicans with combination of FLU/CLT was performed using the CLSI guidelines and time-killing curves. We investigated the anti-hyphal activities of combination of FLU/CLT against C. albicans using XTT and crystal violet assays as well as scanning electron microscopy and expression of HWP1 gene. Results: The interaction of C. albicans with FLU/CLT resulted in synergistic, partial synergistic and indifferent effects. The interaction of FLU/CLT were confirmed by time-killing curves. FLU/CLT combined resulted in the reduction of metabolic activity and hyphae formation in C. albicans. Images taken by scanning electron microscopy indicated the effectiveness on hyphae disruption.
    [Show full text]
  • Eczema Low Cost (TALC) David Chandler 13 in the Community Najeeb Ahmad Safdar & Jane Sterling 6 ABSTRACTS ESSENTIAL DRUGS in DERMATOLOGY Journal Extracts and 1
    An International Journal for Community Skin Health EDITORIAL: PUBLIC HEALTH AND SKIN DISEASE R J Hay DM FRCP record which is often unrecognised. For International Foundation of instance, in the early part of the twenti- Dermatology eth century many countries had policies Professor of Dermatology for the control of scalp ringworm which Faculty of Medicine and Health Sciences ranged from school exclusion orders to special treatment facilities. It resulted in Queen’s University, Belfast, UK partial control but, in the absence of an effective remedy, elimination remained ost of the work of dermato- a distant goal. With the discovery of logists is concerned with the drug, griseofulvin, the potential to the treatment of individ- provide a wider programme based on Mual patients to the highest standards the treatment of communities became achievable with the facilities and skills possible and, in some areas, there was a available. However, it is seldom possible concerted effort to eliminate tinea capi- to apply this to large populations in tis using control teams. Afghan refugee child most parts of the developing world, par- Yaws and leprosy are further exam- ticularly where the lack of resources and ples of diseases where control measures, sparse populations make the adoption of backed by international collaboration, this model of health care unattainable. have focused on elimination of infection In assessing the needs for these groups a by early identification of cases and con- different approach is necessary. tacts and mass drug treatment. Public Health and Skin Skin Disease and the Western Disease World Dermatological public health has sel- In recent years, the focus of public dom been prioritised as a key objec- health in 'western world' dermatology tive in the overall management of has concentrated on the control of the At a Health Centre, Afgooye, Somalia skin diseases, although it has a strong modern epidemic of a non-infectious Photos: Murray McGavin CONTENTS J Comm Dermatol 2005; 2: 1–16 Issue No.
    [Show full text]
  • 204684Orig1s000
    CENTER FOR DRUG EVALUATION AND RESEARCH APPLICATION NUMBER: 204684Orig1s000 OFFICE DIRECTOR MEMO Deputy Office Director Decisional Memo Page 2 of 17 NDA 204,684 Miltefosine Capsules 1. Introduction Leishmania organisms are intracellular protozoan parasites that are transmitted to a mammalian host by the bite of the female phlebotomine sandfly. The main clinical syndromes are visceral leishmaniasis (VL), cutaneous leishmaniasis (CL), and mucosal leishmaniasis (ML). VL is the result of systemic infection and is progressive over months or years. Clinical manifestations include fever, hepatomegaly, splenomegaly, and bone marrow involvement with pancytopenia. VL is fatal if untreated. Liposomal amphotericin B (AmBisome®) was FDA approved in 1997 for the treatment of VL. CL usually presents as one or more skin ulcers at the site of the sandfly bite. In most cases, the ulcer spontaneously resolves within several months, leaving a scar. The goals of therapy are to accelerate healing, decrease morbidity and decrease the risk of relapse, local dissemination, or mucosal dissemination. There are no FDA approved drugs for the treatment of CL. Rarely, CL disseminates from the skin to the naso-oropharyngeal mucosa, resulting in ML. ML can also develop some time after CL spontaneous ulcer healing. The risk of ML is thought to be highest with CL caused by the subgenus Viannia. ML is characterized in the medical literature as progressive with destruction of nasal and pharyngeal structures, and death may occur due to complicating aspiration pneumonia. There are no FDA approved drugs for the treatment of ML. Paladin Therapeutics submitted NDA 204, 684 seeking approval of miltefosine for the treatment of VL caused by L.
    [Show full text]
  • Antifungals, Topical
    Therapeutic Class Overview Antifungals, Topical INTRODUCTION The topical antifungals are available in multiple dosage forms and are indicated for a number of fungal infections and related conditions. In general, these agents are Food and Drug Administration (FDA)-approved for the treatment of cutaneous candidiasis, onychomycosis, seborrheic dermatitis, tinea corporis, tinea cruris, tinea pedis, and tinea versicolor (Clinical Pharmacology 2018). The antifungals may be further classified into the following categories based upon their chemical structures: allylamines (naftifine, terbinafine [only available over the counter (OTC)]), azoles (clotrimazole, econazole, efinaconazole, ketoconazole, luliconazole, miconazole, oxiconazole, sertaconazole, sulconazole), benzylamines (butenafine), hydroxypyridones (ciclopirox), oxaborole (tavaborole), polyenes (nystatin), thiocarbamates (tolnaftate [no FDA-approved formulations]), and miscellaneous (undecylenic acid [no FDA-approved formulations]) (Micromedex 2018). The topical antifungals are available as single entity and/or combination products. Two combination products, nystatin/triamcinolone and Lotrisone (clotrimazole/betamethasone), contain an antifungal and a corticosteroid preparation. The corticosteroid helps to decrease inflammation and indirectly hasten healing time. The other combination product, Vusion (miconazole/zinc oxide/white petrolatum), contains an antifungal and zinc oxide. Zinc oxide acts as a skin protectant and mild astringent with weak antiseptic properties and helps to
    [Show full text]
  • Systemic Antifungal Drug Use in Belgium—
    Received: 7 October 2018 | Revised: 28 March 2019 | Accepted: 14 March 2019 DOI: 10.1111/myc.12912 ORIGINAL ARTICLE Systemic antifungal drug use in Belgium—One of the biggest antifungal consumers in Europe Berdieke Goemaere1 | Katrien Lagrou2,3* | Isabel Spriet4,5 | Marijke Hendrickx1 | Eline Vandael6 | Pierre Becker1 | Boudewijn Catry6,7 1BCCM/IHEM Fungal Collection, Service of Mycology and Aerobiology, Sciensano, Summary Brussels, Belgium Background: Reports on the consumption of systemic antifungal drugs on a national 2 Department of Microbiology and level are scarce although of high interest to compare trends and the associated epi- Immunology, KU Leuven, Leuven, Belgium 3Clinical Department of Laboratory demiology in other countries and to assess the need for antifungal stewardship Medicine, National Reference Centre for programmes. Mycosis, University Hospitals Leuven, Leuven, Belgium Objectives: To estimate patterns of Belgian inpatient and outpatient antifungal use 4Department of Pharmaceutical and and provide reference data for other countries. Pharmacological Sciences, KU Leuven, Methods: Consumption records of antifungals were collected in Belgian hospitals Leuven, Belgium between 2003 and 2016. Primary healthcare data were available for the azoles for 5Pharmacy Department, University Hospitals Leuven, Leuven, Belgium the period 2010-2016. 6 Healthcare‐Associated Infections and Results: The majority of the antifungal consumption resulted from prescriptions of Antimicrobial Resistance, Sciensano, Brussels, Belgium fluconazole and itraconazole in the ambulatory care while hospitals were responsible 7Faculty of Medicine, Université Libre de for only 6.4% of the total national consumption and echinocandin use was limited. Bruxelles (ULB), Brussels, Belgium The annual average antifungal consumption in hospitals decreased significantly by Correspondence nearly 25% between 2003 and 2016, due to a decrease solely in non-university hos- Berdieke Goemaere, Sciensano, Mycology pitals.
    [Show full text]
  • Therapeutic Class Overview Antifungals, Topical
    Therapeutic Class Overview Antifungals, Topical INTRODUCTION The topical antifungals are available in multiple dosage forms and are indicated for a number of fungal infections and related conditions. In general, these agents are Food and Drug Administration (FDA)-approved for the treatment of cutaneous candidiasis, onychomycosis, seborrheic dermatitis, tinea corporis, tinea cruris, tinea pedis, and tinea versicolor (Clinical Pharmacology 2018). The antifungals may be further classified into the following categories based upon their chemical structures: allylamines (naftifine, terbinafine [only available over the counter (OTC)]), azoles (clotrimazole, econazole, efinaconazole, ketoconazole, luliconazole, miconazole, oxiconazole, sertaconazole, sulconazole), benzylamines (butenafine), hydroxypyridones (ciclopirox), oxaborole (tavaborole), polyenes (nystatin), thiocarbamates (tolnaftate [no FDA-approved formulations]), and miscellaneous (undecylenic acid [no FDA-approved formulations]) (Micromedex 2018). The topical antifungals are available as single entity and/or combination products. Two combination products, nystatin/triamcinolone and Lotrisone (clotrimazole/betamethasone), contain an antifungal and a corticosteroid preparation. The corticosteroid helps to decrease inflammation and indirectly hasten healing time. The other combination product, Vusion (miconazole/zinc oxide/white petrolatum), contains an antifungal and zinc oxide. Zinc oxide acts as a skin protectant and mild astringent with weak antiseptic properties and helps to
    [Show full text]
  • Below Chart Lists Over-The-Counter (OTC) Medicines Considered Low Risk for Pregnant Women When Taken for the Occasional Mild Illness
    Below chart lists over-the-counter (OTC) medicines considered low risk for pregnant women when taken for the occasional mild illness. It also mentions a few that are not safe. A few brand names are listed as examples, but there are many more on the market. Of course, nothing is 100 percent safe for all women, so it's a good idea to check with your doctor before taking any kind of medicine during pregnancy – even an over-the-counter product. Don't take more than the recommended dose and, if possible, avoid taking anything during your first trimester, when your developing baby is most vulnerable. NOTE: If you have a question about the safety of any medication during pregnancy, visit the Organization of Teratology Information Specialists Web site. There you'll find fact sheets on various drugs and exposures that can affect your baby as well as a list of teratogen information services that you can contact. Problem Safe to take Heartburn, gas and Antacids for heartburn (Maalox, Mylanta, Rolaids, Tums) bloating, upset stomach Simethicone for gas pains (Gas-X, Maalox Anti-Gas, Mylanta Gas, Mylicon) Cough or cold Guaifenesin, an expectorant (Hytuss, Mucinex, Naldecon Senior EX, Robitussin) Dextromethorphan, a cough suppressant (Benylin Adult, Robitussin Maximum Strength Cough, Scot-Tussin DM, Vicks 44 Cough Relief) Guaifenesin plus dextromethorphan (Benylin Expectorant, Robitussin DM, Vicks 44E) Cough drops Vicks VapoRub Not safe to take: Cold remedies that contain alcohol The decongestants pseudoephedrine and phenylephrine, which can affect blood
    [Show full text]
  • NATACYN® (Natamycin Ophthalmic Suspension) 5% Sterile
    NATACYN® (natamycin ophthalmic suspension) 5% Sterile DESCRIPTION: NATACYN® (natamycin ophthalmic suspension) 5% is a sterile, antifungal drug for topical ophthalmic administration. Each mL of NATACYN® (natamycin ophthalmic suspension) contains: Active: natamycin 5% (50 mg). Preservative: benzalkonium chloride 0.02%. Inactive: sodium hydroxide and/or hydrochloric acid (neutralized to adjust the pH), purified water. The active ingredient is represented by the chemical structure: Established Name: Natamycin Molecular Formula: C33H47NO13 Molecular Weight: 665.73 g/mol Chemical Name: Stereoisomer of 22-[(3-amino-3,6-dideoxy- β-D-mannopyranosyl)oxy]-1,3,26- trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo[22.3.1.05,7] octacosa-8,14,16,18,20-pentaene-25- carboxylic acid. Other: Pimaricin The pH range is 5.0-7.5. CLINICAL PHARMACOLOGY: Natamycin is a tetraene polyene antibiotic derived from Streptomyces natalensis. It possesses in vitro activity against a variety of yeast and filamentous fungi, including Candida, Aspergillus, Cephalosporium, Fusarium and Penicillium. The mechanism of action appears to be through binding of the molecule to the sterol moiety of the fungal cell membrane. The polyenesterol complex alters the permeability of the membrane to produce depletion of essential cellular constituents. Although the activity against fungi is dose-related, natamycin is predominantly fungicidal. Natamycin is not effective in vitro against gram-positive or gram- negative bacteria. Topical administration appears to produce effective concentrations of natamycin within the corneal stroma but not in intraocular fluid. Systemic absorption should not be expected following topical administration of NATACYN® (natamycin ophthalmic suspension) 5%. As with other polyene antibiotics, absorption from the gastrointestinal tract is very poor.
    [Show full text]
  • Infectious Keratitis: Short Answers
    Q Infectious keratitis: Short answers What is the #1 bacterium in CL-related K ulcer? A Infectious keratitis: Short answers What is the #1 bacterium in CL-related K ulcer? Pseudomonas Infectious keratitis: Short answers Pseudomonas corneal ulcer associated with CL wear Q Infectious keratitis: Short answers What is the #1 bacterium in CL-related K ulcer? Pseudomonas What is the #1 risk factor for Acanthamoeba keratitis? A Infectious keratitis: Short answers What is the #1 bacterium in CL-related K ulcer? Pseudomonas What is the #1 risk factor for Acanthamoeba keratitis? CL wear Infectious keratitis: Short answers Acanthamoeba keratitis associated with CL wear Q Infectious keratitis: Short answers What is the #1 bacterium in CL-related K ulcer? Pseudomonas What is the #1 risk factor for Acanthamoeba keratitis? CL wear What are the three main culprits in fungal keratitis? What is the topical antifungal of choice for each? Fusarium:fungus 1 Topical…natamycin Aspergillisfungus 2 and Candida:fungus 3 A Infectious keratitis: Short answers What is the #1 bacterium in CL-related K ulcer? Pseudomonas What is the #1 risk factor for Acanthamoeba keratitis? CL wear What are the three main culprits in fungal keratitis? What is the topical antifungal of choice for each? Candida: Topical…natamycin Aspergillis and Fusarium: Q Infectious keratitis: Short answers What is the #1 bacterium in CL-related K ulcer? Pseudomonas What is the #1 risk factor for Acanthamoeba keratitis? CL wear What are the three main culprits in fungal keratitis?
    [Show full text]
  • Updates in Ocular Antifungal Pharmacotherapy: Formulation and Clinical Perspectives
    Current Fungal Infection Reports (2019) 13:45–58 https://doi.org/10.1007/s12281-019-00338-6 PHARMACOLOGY AND PHARMACODYNAMICS OF ANTIFUNGAL AGENTS (N BEYDA, SECTION EDITOR) Updates in Ocular Antifungal Pharmacotherapy: Formulation and Clinical Perspectives Ruchi Thakkar1,2 & Akash Patil1,2 & Tabish Mehraj1,2 & Narendar Dudhipala1,2 & Soumyajit Majumdar1,2 Published online: 2 May 2019 # Springer Science+Business Media, LLC, part of Springer Nature 2019 Abstract Purpose of Review In this review, a compilation on the current antifungal pharmacotherapy is discussed, with emphases on the updates in the formulation and clinical approaches of the routinely used antifungal drugs in ocular therapy. Recent Findings Natamycin (Natacyn® eye drops) remains the only approved medication in the management of ocular fungal infections. This monotherapy shows therapeutic outcomes in superficial ocular fungal infections, but in case of deep-seated mycoses or endophthalmitis, successful therapeutic outcomes are infrequent, as a result of which alternative therapies are sought. In such cases, amphotericin B, azoles, and echinocandins are used off-label, either in combination with natamycin or with each other (frequently) or as standalone monotherapies, and have provided effective therapeutic outcomes. Summary In recent times, amphotericin B, azoles, and echinocandins have come to occupy an important niche in ocular antifungal pharmacotherapy, along with natamycin (still the preferred choice in most clinical cases), in the management of ocular fungal infections.
    [Show full text]
  • Natamycin Ophthalmic Suspension)5% Sterile
    NDA 50-514/S-009 Page 3 Natacyn® (natamycin ophthalmic suspension)5% Sterile DESCRIPTION: NATACYN® (natamycin ophthalmic suspension) 5% is a sterile, antifungal drug for topical ophthalmic administration. Each mL of the suspension contains: Active: natamycin 5% (50mg). Preservative: benzalkonium chloride 0.02%. Inactive: sodium hydroxide and/or hydrochloric acid (neutralized to adjust the pH), purified water. The active ingredient is represented by the chemical structure: Established name: Natamycin Chemical Structure Molecular Formula: C33H47NO13 Molecular Weight: 665.73 Chemical name: Stereoisomer of 22-[(3-amino-3,6-dideoxy- β-D-mannopyranosyl)oxy]-1,3,26­ trihydroxy-12- methyl-10-oxo-6,11,28- trioxatricyclo[22.3.1.05,7] octacosa-8,14,16,18,20-pentaene-25-carboxylic acid. Other: Pimaricin The pH range is 5.0 – 7.5. CLINICAL PHARMACOLOGY: Natamycin is a tetraene polyene antibiotic derived from Streptomyces natalensis. It possesses in vitro activity against a variety of yeast and filamentous fungi, including Candida, Aspergillus, Cephalosporium, Fusarium and Penicillium. The mechanism of action appears to be through binding of the molecule to the sterol moiety of the fungal cell membrane. The polyenesterol complex alters the permeability of the membrane to produce depletion of essential cellular constituents. Although the activity against fungi is dose-related, natamycin is predominantly fungicidal.* Natamycin is not effective in vitro against gram-positive or gram-negative bacteria. Topical administration appears to produce effective concentrations of natamycin within the corneal stroma but not in intraocular fluid. Systemic absorption should not be expected following topical administration of NATACYN® (natamycin ophthalmic suspension) 5%. As with other polyene antibiotics, absorption from the gastrointestinal tract is very poor.
    [Show full text]